The company has signed agreement with Israel's Technion university to develop anti-cancer drugs.
Sun Pharmaceutical Industries stock was up 1% at Rs. 1098.
The stock has hit a high of Rs. 1104 and a low of Rs. 1086.
The company has inked a pact with Israel's Technion university to develop anti-cancer drugs.
This agreement aims at the development of a joint project, based on new findings by Nobel Prize laureate Distinguished Professor Aaron Ciechanover, Dr. Gila Maor and Professor Ofer Binah, that can potentially lead to the development of novel anti-cancer drugs. The pre-clinical research was funded thus far by Dr. Alfred Mann.
No comments:
Post a Comment